Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, the social discussions reflect strong agreement with the study's conclusions, with many posts emphasizing the potential harm from long-term use of anticholinergic medications. Words such as 'significant', 'increased risk', and phrases like 'should be reconsidered' convey a tone of urgency and concern, illustrating that participants view this research as a pivotal call for reevaluating medication use in older populations.
Most discussions support the connection between anticholinergic drugs and increased dementia risk, showing consensus on the study's findings.
Many posts highlight the significance of the research, suggesting high curiosity and concern about the implications.
Several participants reference specific studies, mention risk percentages, and debate the ethical and medical impacts, indicating deep engagement.
The widespread referencing of risk estimates and calls for cautious prescribing demonstrate that discussions see this research as highly impactful for public health and medical practice.
@quantian1 nows a good time to remind everyone that chronic use of anticholinergics like benadryl will cause cognitive impairment and may increase your odds of contracting dementia later on by >60% https://t.co/kx9EzZUSRG
But the new libido drug causing mild nausea is too dangerous?
Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
4/ Now we have increasing evidence from longitudinal studies that anticholinergic exposure increases dementia risk: "The population-attributable fraction associated w/ anticholinergic drug exposure during the 1-11 years before diagnosis was 10.3%." https://t.co/8MNHYJTUF4 https://t.co/YhIztctcBm
Maybe we can get better insurance coverage for mirabegron! Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/RZSSGbQ8Bn
‘Anticholinergic Drug Exposure and the Risk of Dementia, A Nested Case-Control Study’ Coupland et al. Further evidence of anti-cholinergics risks and dementia https://t.co/8V2gxGeOZf https://t.co/DwpMtusDXo
This video explores strategies to enhance well-being during pregnancy, focusing on sleep, nutrition, movement, grooming, and nesting. It offers practical tips for expecting mothers to feel great throughout pregnancy.
This video shares personal experiences with the American mental healthcare system and the lasting damage caused by systemic failures. It emphasizes the need for reform and highlights the importance of informed consent…
@resistrinker Benadryl and other anticholinergics linked to increased risk of dementia https://t.co/LRNSPBosXp
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/ielelrA9hG
RT @SatchinPanda: Drugs that increase #dementia risk anticholinergic antidepressants, antiparkinson drugs, antipsychotic drugs, bladd…
@NeherBirgitta @Yash25571056 You are ignorant and insolent. 'Long-term use of anticholinergic drugs is associated with an increased risk of dementia. Anticholinergics block acetylcholine receptors in the brain, which can impair cognitive function.' https://t.co/IMsQsfZm4y
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/8g3bWhmOsO
@quantian1 nows a good time to remind everyone that chronic use of anticholinergics like benadryl will cause cognitive impairment and may increase your odds of contracting dementia later on by >60% https://t.co/kx9EzZUSRG
@CTCaveman @eliotmuir Some studies have linked blocking histamine to an increased risk of dementia due to anticholinergic properties (reduced acetylcholine) so it may be a bigger deal than you think. https://t.co/hbTbq0mbKm
3/ anticholinergic medication…” https://t.co/T4TE02n0dt
A 2019 study found anticholinergic drugs were associated with a ↑ risk of #dementia. Overall, anticholinergic antidepressants, antipsychotic, anti-Parkinson’s, bladder, & epilepsy drugs were associated with the highest dementia risks #Gibraltar https://t.co/jDu3HCM9IG
@jimbovelure @atomicaceso @ChrisPalmerMD In UK research, those prescribed anticholinergic drugs, including ADs, are at a 50% ⬆️ risk of dementia. The researchers suggested that adverse effects may result in about 20,000 cases of dementia per year in the UK alone. Clearly, more research needed? https://t.co/myzEPFmFYZ
@Cathi_Bea @ElaineBelz https://t.co/aRmx5P2K5Y
#Benadryl https://t.co/aRmx5P2K5Y
RT @Machell49934776: @Billy75Williams @ElaineBelz https://t.co/aRmx5P2K5Y
@Billy75Williams @ElaineBelz https://t.co/aRmx5P2K5Y
@ElaineBelz @Billy75Williams https://t.co/aRmx5P2K5Y
@Billy75Williams @ElaineBelz https://t.co/aRmx5P2K5Y
Anticholinergic Drug Exposure and the Risk of Dementiaというのはだいぶ有名な話となりつつありますが、ある程度パワーのある論文というとこれとかになりますでしょうか。少し古いですが、孫引きもふくめて、今一度読み解いてみてくださいませ。 https://t.co/KoG7xgCwWF
RT @wortgewalt3: @angryhacademic It may be worthwhile to mention that 1st gen antihistamines are suspected to cause and/or contribute to on…
@angryhacademic It may be worthwhile to mention that 1st gen antihistamines are suspected to cause and/or contribute to onset of dementia. E.g. https://t.co/jd8Z52v7dN Been wondering what 2nd and 3rd gen might do to the brain, seeing as our BBB seems to have trouble filtering even small pebbles
Please don't take Benedryl https://t.co/v3Kon8jLP1
RT @keisuke4713: 認知症risk https://t.co/pEtUDAaT6X 累積的抗コリン薬使用量多い程⇨認知症risk⬆️ 三環系抗鬱薬 第一世代抗ヒスタミン薬 過活動膀胱抗ムスカリン薬 薬物中止後もrisk残る https://t.co/ec92HY…
RT @DrMattThomas: @SiobhanAbrahams Three years of daily amitriptyline use associated with 50% increased odds of dementia. Should we be expo…
@SiobhanAbrahams Three years of daily amitriptyline use associated with 50% increased odds of dementia. Should we be exposing our patients to this risk without evidence of benefit. Note cochrane review did find some benefit from duloxetine without anticholinergic risk https://t.co/ntBiO9klRK
Is the risk of dementia among persons 55 years or older associated with the use of different types of anticholinergic medication? https://t.co/YIHBc025vo
@fT4DrpIPd60ozSN @shinyaku_online そして心配なのは認知症リスクです。 プロバンサインと異なり、オキシブチニンはこの資料において「膀胱抗ムスカリン薬（Bladder antimuscarinic drugs）」に分類されていて、「リスクが大幅に増加」となっているのです。 https://t.co/CG7PVzkWan
プロバンサインの認知症リスクについて、あくまでもひとつの参考ですが、こんな資料があります。 https://t.co/CG7PVzkWan
Anticholinergic Drug Exposure and the Risk of Dementia (2019) [
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/FMRtN0sLX3 @picardonhealth
3/ Which OTC drugs did the studies mention? Research has found a statistically significant link between dementia and common OTC drugs like antihistamine medications, sleep aids, motion sickness medication, & various cold medicines. Source: https://t.co/MdkqMc7rUZ READ BELOW: https://t.co/jquZ4riuyw
RT @organichemusic: @TMaritanoAquino @donutdisaster It's not safe in older populations due to the sedation increasing risk of falls. It's g…
@TMaritanoAquino @donutdisaster It's not safe in older populations due to the sedation increasing risk of falls. It's generally not something I would want to take long-term due to increased risk of dementia with certain anticholinergics. https://t.co/E9j10p9rcn
@anandabits IMO it’s a risk/benefit decision, and there needs to be informed consent about risks of anticholinergic drugs and the risk of dementia. Risk of dementia goes up with cumulative exposure to anticholinergics - and not just scop https://t.co/1TQ4ALsrWU
RT @PanDanTag: @arikouts @ImmortelleXIII @MikiLaMalice Tiens là c'est avéré, +49% de cas de démence 1 à 11 ans après la prise du médicament…
RT @PanDanTag: @arikouts @ImmortelleXIII @MikiLaMalice Tiens là c'est avéré, +49% de cas de démence 1 à 11 ans après la prise du médicament…
@arikouts @ImmortelleXIII @MikiLaMalice Tiens là c'est avéré, +49% de cas de démence 1 à 11 ans après la prise du médicament https://t.co/jN9ucroaQf
RT @haidut: @healthygutgirl @Mangan150 @Epikratw These absird claims are based on a one OBSERVATIONAL study, so the link was never proven t…
@healthygutgirl @Mangan150 @Epikratw These absird claims are based on a one OBSERVATIONAL study, so the link was never proven to be causal. https://t.co/mC7Ey81Tgt Btw, the claim that anticholinergic drugs may cause AD is based on the already-discredited theory that acetylcholine is low in AD and raising it is good.
Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/WY9VTMtBEU via @JAMAInternalMed part of @JAMANetwork
RT @keisuke4713: 認知症risk https://t.co/pEtUDAaT6X 累積的抗コリン薬使用量多い程⇨認知症risk⬆️ 三環系抗鬱薬 第一世代抗ヒスタミン薬 過活動膀胱抗ムスカリン薬 薬物中止後もrisk残る https://t.co/ec92HY…
https://t.co/p2cTMocoKb
RT @keisuke4713: 認知症risk https://t.co/pEtUDAaT6X 累積的抗コリン薬使用量多い程⇨認知症risk⬆️ 三環系抗鬱薬 第一世代抗ヒスタミン薬 過活動膀胱抗ムスカリン薬 薬物中止後もrisk残る https://t.co/ec92HY…
認知症risk https://t.co/pEtUDAaT6X 累積的抗コリン薬使用量多い程⇨認知症risk⬆️ 三環系抗鬱薬 第一世代抗ヒスタミン薬 過活動膀胱抗ムスカリン薬 薬物中止後もrisk残る https://t.co/ec92HYeFcg 55歳以上抗コリン薬長期使用⇨認知症risk 抗コリン作用抗鬱薬、抗パーキンソン薬、膀胱抗ムスカリン薬
Anticholinergic Drug Exposure and the Risk of Dementia A Nested Case-Control Study https://t.co/cS9ncda5DT This large, nested case-control study found an increased risk of dementia associated with anticholinergic medication use. 1/
【認知症と抗コリン作用】 認知機能の低下には服用している薬の総コリン負荷が問題となる 抗コリン作用のある ☑️抗ヒスタミン ☑️H2ブロッカー ☑️制吐薬【プリンペラン】 等の薬は把握し 漫然と使用してないか確認 他の抗コリン作用のない薬に変更 できないか考慮したい https://t.co/WZdqDz1rB8
@MMMalign @ultimape Quite evil indeed. https://t.co/oWzMsu2Lii
RT @DrSaripanidis: @ProfRobHoward Antidepressant administration to the elderly is unethical because it increases dementia! https://t.co/PU5…
RT @DrSaripanidis: @ProfRobHoward Antidepressant administration to the elderly is unethical because it increases dementia! https://t.co/PU5…
RT @DrSaripanidis: @ProfRobHoward Antidepressant administration to the elderly is unethical because it increases dementia! https://t.co/PU5…
@ProfRobHoward Antidepressant administration to the elderly is unethical because it increases dementia! https://t.co/PU53stU9AP https://t.co/qw3TkRfCp9 https://t.co/rEOI7xWi76 https://t.co/6fIuGos99S https://t.co/ugx1W5ruyJ
@maxgray26769167 @KMOoceanGIRL @lib_gosnell https://t.co/QHNTFGygO8
RT @HengartnerMP: @CVolkmannMD @PloederlM There are some analyses on anticholinergic burden, if that fits into your concept of causal mecha…
@CVolkmannMD @PloederlM There are some analyses on anticholinergic burden, if that fits into your concept of causal mechanism. For example: https://t.co/49tf1NWngO
RT @HengartnerMP: @joannamoncrieff @CEP_UK Anticholinergic effects of antipsychtics (and various other drugs frequently prescribed in schiz…
RT @HengartnerMP: @joannamoncrieff @CEP_UK Anticholinergic effects of antipsychtics (and various other drugs frequently prescribed in schiz…
RT @HengartnerMP: @joannamoncrieff @CEP_UK Anticholinergic effects of antipsychtics (and various other drugs frequently prescribed in schiz…
@joannamoncrieff @CEP_UK Anticholinergic effects of antipsychtics (and various other drugs frequently prescribed in schizophrenia) most likely contribute to cognitive impairments and dementia. Repeatedly demonstrated in well-controlled studies: https://t.co/IR7LJrRyWB https://t.co/49tf1NWngO
Journal Club - Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/fj9078mAwQ https://t.co/PZnXW5B5N8
Journal Club - Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/TLB1O6BrPn https://t.co/m6KqQ9utGf
@RyanMarino @MdRisette I think this was the study I saw: https://t.co/aDmsmvjvlp
RT @cpontesg: Significant increases in risk of dementia for anticholinergic antidepressants (OR [1.29; 95% CI, 1.24-1.34), antiparkinson (1…
Significant increases in risk of dementia for anticholinergic antidepressants (OR [1.29; 95% CI, 1.24-1.34), antiparkinson (1.52; 1.16-2.00), antipsychotics (1.70; 1.53-1.90), bladder antimuscarinics (1.65; 1.56-1.75), & antiepileptics (1.39; 1.22-1.57) https://t.co/0t25e2FPfX
RT @psychunseen: 4/ Now we have increasing evidence from longitudinal studies that anticholinergic exposure increases dementia risk: "Th…
RT @psychunseen: 4/ Now we have increasing evidence from longitudinal studies that anticholinergic exposure increases dementia risk: "Th…
4/ Now we have increasing evidence from longitudinal studies that anticholinergic exposure increases dementia risk: "The population-attributable fraction associated w/ anticholinergic drug exposure during the 1-11 years before diagnosis was 10.3%." https://t.co/8MNHYJTUF4 https://t.co/YhIztctcBm
Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/58KUALRZaP via @JAMAInternalMed part of @JAMANetwork
DW. Anticholinergic drugs are widely used in rehabilitation. This paper supports critical review all drug intake. Though the risk of dementia may be small compared with all else, the risk of dementia from anticholinergics should still be considered. https://t.co/1NDBRn0N5a
Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/1000ymoEc7 via @JAMAInternalMed part of @JAMANetwork
https://t.co/AqK7IKZgUO So #antidepressants, #antipsychotic drugs, bladder #antimuscarinics, and #antiepileptic drugs. So #gabapentin for #pain management is one.
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
@Deedoherty2 @vkivlighan #Anticholinergic Drug Exposure and the Risk of #Dementia https://t.co/lM3p51mIH7
@Hiroki_kyunoar 一応ソースを載せておきます。 https://t.co/DxCU0bo8Vv
RT @deoanzai: アルツハイマーの高齢者には抗コリン剤の投与を受けていた人が多い、というJAMA論文。とくに抗うつ、抗パーキンソン、膀胱弛緩の薬。投与量が多く、長かった人ほどアルツハイマーが多い。 https://t.co/ISWR2zjLSO
RT @JAMAInternalMed: Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
Anticholinergic Drug Exposure and the Risk of Dementia https://t.co/Ybj5EwX17z #MostCited
RT @DrEvgenyLegedin: @drjanaway A case-control study in England: exposure to strong anticholinergic drugs, including antidepressants & anti…
RT @DrEvgenyLegedin: UK study found that the risk of developing #dementia increased from 6% in the lowest overall anticholinergic (ACH) exp…
RT @MissKelsey_RX: Presenting a Journal Club on: Anticholinergic Drug Exposure and the Risk of Dementia (A Nested Case-Control Study) for d…
Presenting a Journal Club on: Anticholinergic Drug Exposure and the Risk of Dementia (A Nested Case-Control Study) for discovery today!
RT @CaregiverAlly: According to the research, published in @JAMAInternalMed, discovered the increased odds of #dementia in people 55 and ol…
RT @HealthJogo: There is an increased need for #PFMT #biofeedback like @HealthJogo for #incontinence given #dementia risk from #anticholine…
@Grumpa https://t.co/cYydAC10oy
There is an increased need for #PFMT #biofeedback like @HealthJogo for #incontinence given #dementia risk from #anticholinergic drugs #medtwitter #urology https://t.co/cYydAC10oy
RT @StephFarrel: @psychunseen Recent studies suggest that long term use of anticholinergics ( antiparkinson drugs, antipsychotic drugs, bla…
Recent studies suggest that long term use of #anticholinergics ( antiparkinson drugs, #antipsychotic drugs, bladder antimuscarinics, #antidepressants and #antiepileptic )drugs were associated with COGNITIVE decline and DEMENTIA #drugs #pharma https://t.co/0Y2lk5NcH2
RT @StephFarrel: @psychunseen Recent studies suggest that long term use of anticholinergics ( antiparkinson drugs, antipsychotic drugs, bla…
@psychunseen Recent studies suggest that long term use of anticholinergics ( antiparkinson drugs, antipsychotic drugs, bladder antimuscarinics, and antiepileptic )drugs were associated with cognitive decline and dementia. https://t.co/0Y2lk5NcH2
Interesting study shows that anti-cholinergic drugs cause cognitive decline. This makes sense, because it stops you from firing one of the most common "do this/concentrate" signals in the brain. Like reverse adderall. https://t.co/Kq2Zzq1edm
@zo_zo_81 sorry, not AD, but dementia more generally. https://t.co/8MNHYJTUF4
RT @DrEvgenyLegedin: UK study found that the risk of developing #dementia increased from 6% in the lowest overall anticholinergic (ACH) exp…
RT @DrEvgenyLegedin: @drjanaway A case-control study in England: exposure to strong anticholinergic drugs, including antidepressants & anti…
RT @DrEvgenyLegedin: UK study found that the risk of developing #dementia increased from 6% in the lowest overall anticholinergic (ACH) exp…
RT @DrEvgenyLegedin: UK study found that the risk of developing #dementia increased from 6% in the lowest overall anticholinergic (ACH) exp…
@ProfRobHoward @CoyneoftheRealm There is legitimate cause for concern, unless the University of Nottingham has gone antipsychiatry as well. https://t.co/9lXK58YJNp
RT @UnravelMedicine: We critically analyzed a study published in @JAMAInternalMed investigating the risk of dementia with anticholinergic d…
Journal Club - Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/fYaAuhNpMt https://t.co/adneyQiqmX
Journal Club - Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/Hfo85icfg7 https://t.co/IZuBJRw7Ji
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. - PubMed - NCBI https://t.co/6mnp94ciz7
Bordel, je m’attendais pas à un tel chiffre. C’est archi-bourrin quand même… #Anticholinergique #Démence #Risque Source : Univadis au sujet de Anticholinergic Drug Exposure and the Risk of Dementia. A Nested Case-Control Study https://t.co/ufR2U5Ss0Z https://t.co/ZscT6HWOZj
Your medicine have an unwanted Side effect #ageism Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/AX70ifQMoD
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/8itcTbOfrp
RT @DrMamaKai: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JA…
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network @JAMAInternalMed @JAMANetwork https://t.co/QacHfdseiq
@TedDinan Without looking at the article, I guessed it was about choline. Fun effects found on vagus nerve/inflammation in mouse models: https://t.co/QJ8pexxRyD It fits associations between anticholinergenic drugs and dimentia risk https://t.co/APMlzqprXP https://t.co/hh6qhAN1vg
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/SEIFBszFA5
Anticholinergic drug exposure and the risk of dementia: A nested case-control study https://t.co/7CAbbFJImw
Anticholinergic Drug Exposure and the Risk of Dementia A Nested Case-Control Study https://t.co/A4Z1ayz7UO
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. https://t.co/FjdlniFJre
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/KABXc04zLq
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/3fBFvpHFdc
RT @neurologiagye: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. - PubMed - NCBI https://t.co/5cDhqE…
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. - PubMed - NCBI https://t.co/5cDhqE0UkQ
RT @estmannmd: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JA…
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/RFgNzqQN9U
RT @UnravelMedicine: We critically analyzed a study published in @JAMAInternalMed investigating the risk of dementia with anticholinergic d…
@UBC researchers @MohitsodhiUBC @etminanm @farzinkhosrow have critically evaluated the recent @JAMAInternalMed paper on anticholinergics and dementia: https://t.co/hPk4pMNUzo
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. https://t.co/uVQu6H3JLJ
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/Gix5nGgQtg
RT @UnravelMedicine: We critically analyzed a study published in @JAMAInternalMed investigating the risk of dementia with anticholinergic d…
RT @UnravelMedicine: We critically analyzed a study published in @JAMAInternalMed investigating the risk of dementia with anticholinergic d…
We critically analyzed a study published in @JAMAInternalMed investigating the risk of dementia with anticholinergic drug use https://t.co/aC1zaQT1gX #JAMA #InternalMedicine #Medicine #neurology #dementia #epidemiology #pharmacology #science https://t.co/DAyLgPpDKA
RT @NeilFlochMD: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment |…
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/5yyEOl0T6l
RT @dramypark: Maybe we can get better insurance coverage for mirabegron! Anticholinergic Drug Exposure and the Risk of Dementia: A Nested…
"These findings highlight the importance of reducing exposure to anticholinergic drugs in middle-aged and older people." Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. https://t.co/utD0RPsRZU
RT @CRPV_Limoges: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment |…
RT @CRPV_Limoges: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment |…
RT @CRPV_Limoges: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment |…
RT @CRPV_Limoges: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment |…
RT @CRPV_Limoges: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment |…
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/3Q6Cz2i0mE
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. Published online June 24, 2019. https://t.co/W2GdDNpEKE
RT @rachelsrubin1: But the new libido drug causing mild nausea is too dangerous?
RT @rachelsrubin1: But the new libido drug causing mild nausea is too dangerous?
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study https://t.co/suSMtfrWW1
But the new libido drug causing mild nausea is too dangerous?
RT @dramypark: Maybe we can get better insurance coverage for mirabegron! Anticholinergic Drug Exposure and the Risk of Dementia: A Nested…
Maybe we can get better insurance coverage for mirabegron! Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/RZSSGbQ8Bn
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/KxQQ8MGkGz
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. https://t.co/iPNK3TruRK
“These findings highlight the importance of reducing exposure to anticholinergic drugs in middle-aged and older people.” Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | JAMA Internal Medicine | https://t.co/0ubNuO7BGD
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/8pvaX27A07
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | JAMA Internal Medicine | Evidence gets more and more solid, but the OR was 1.06 +/- .03. Not huge.... https://t.co/AtNCazd8Me
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study | Dementia and Cognitive Impairment | JAMA Internal Medicine | JAMA Network https://t.co/eBqETCsS6F
RT @GrahamStretch: ‘Anticholinergic Drug Exposure and the Risk of Dementia, A Nested Case-Control Study’ Coupland et al. Further evidence o…
RT @GrahamStretch: ‘Anticholinergic Drug Exposure and the Risk of Dementia, A Nested Case-Control Study’ Coupland et al. Further evidence o…
‘Anticholinergic Drug Exposure and the Risk of Dementia, A Nested Case-Control Study’ Coupland et al. Further evidence of anti-cholinergics risks and dementia https://t.co/8V2gxGeOZf https://t.co/DwpMtusDXo
JAMA Intern Med. 2019;179(8):1084–93. https://doi.org/10.1001/ jamainternmed.2019.0677. 70. Rosenberg GA. Neurological diseases in relation to the blood ...
... JAMA Intern Med. Published online June 24, 2019. doi:10.1001/jamainternmed.2019.0677. Dal Negro, R. (2009). Pulmonary effects of nebivolol. Therapeutic ...
If you or a loved one have been involved in an accident, call immediately and get a FREE accident ev
JAMA Intern Med Care Pharm 2014; 20: 130. 2019; doi: 10.1001/jamainternmed.2019.0677. 2011; 108: 1132. 4. Coyne KS, Sexton CC, Bell JA et al: The preva- 7 ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Dawood O, El-Zawahry A. Mirabegron. In: StatPearls. StatPearls Publishing; 2024 ...
JAMA Intern Med. Published online June 24, 2019. doi:10.1001/ jamainternalmed.2019.0677. Welk B, McArthur E. Increased risk of dementia among patients with ...
JAMA Intern Med. Published online June 24, 2019. doi:10.1001/jamainternmed.2019.0677. Further information. Always consult your healthcare provider to ensure ...
doi:10.1001/ 2019;76(7):747-748. doi:10.1001/jamaneurol.2019.0974 jamainternmed.2019.0677. 69 Ferreira JJ, Lees A, Rocha JF, et al. Opicapone as an adjunct.
JAMA Intern Med. 2019;179(8): 6398 Inst. 2018;110(11):1216-1221. doi:10.1093/jnci/djy036 1084-1093. doi:10.1001/jamainternmed.2019.0677 37. Albarqouni L ...
org/10.1001/jamainternmed.2019.0677 2. Risacher, S. L., et al. (2016). Association between anticholinergic medication use and brain metabolism and atrophy ...
JAMA Internal Medicine, 179(8), 1084–1093. https://doi.org/10.1001/jamainternmed. 2019.0677 2. Risacher, S. L., et al. (2016).
org/10.1001/jamainternmed.2019.0677 2. Risacher, S. L., et al. (2016). Association between anticholinergic medication use and brain metabolism and atrophy ...
org/10.1001/jamainternmed.2019.0677 2. Risacher, S. L., et al. (2016). Association between anticholinergic medication use and brain metabolism and atrophy ...
JAMA Intern Med. 2019;179:1084-1093. [PMID: 31233095] doi: 10.1001/jamainternmed.2019.0677. Resource for Question 16. PubMed. Filippini T, Malavolti M, Whelton ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
org/10.1001/jamainternmed.2019.0677 2. Risacher, S. L., et al. (2016). Association between anticholinergic medication use and brain ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
Source: Anticholinergic Drug Exposure and the Risk of DementiaA Nested Case-Control Study doi: [10.1001/jamainternmed.2019.0677](http: // ...
... 10.1001/jamainternmed.2019.0677). Caring for someone with chronic conditions means making complex decisions under real pressures ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Why do I share this? I believe it's important to teach the ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. Contacts. Media Contact For BlueWind Medical Jenna Kane
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
47 likes, 7 comments - foodiefarmacist on February 9, 2025: " Benadryl & Brain Health—What You Need to Know If you're reaching for Benadryl ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
Start with a check of exterior water sources. Are your downspouts piped away from the foundation? Is there a water flow pattern that causes ...
... JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677 Why do I share this? I believe it's important to teach the ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... A Nested Case-Control Study. JAMA Intern Med. 2019 Aug 1;179(8):1084-1093. doi: 10.1001/jamainternmed.2019.0677".
JAMA Intern Med. 2019;179(8):1084–1093. doi:10.1001/jamainternmed.2019.0677. 834 https://doi.org/10.2147/IJWH.S379808 International Journal ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084–1093. doi:10.1001/jamainternmed.2019.0677 31. Yoo PB, Woock JP, Grill WM. Bladder activation by selective ...
JAMA internal medicine 179, 1084-1093, doi:10.1001/jamainternmed.2019.0677 (2019). 10.Anticholinergic drugs and risk of dementia: case ...
JAMA Intern Med. Published online June 24, 2019. doi:10.1001/jamainternmed.2019.0677. Newsletter. Stay informed on drug updates, treatment ...
JAMA Intern Med. 2019;179(8):1084-1093. doi: 10.1001/jamainternmed.2019.0677. 46. Richardson K, Fox C, Maidment I, et al. Anticholinergic ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
2019.0677. Gray SL, et al. JAMA Intern Med. 2015;doi:10.1001/jamainternmed.2014.7663. Richardson K, et al. BMJ.
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019;179(8):1084-1093. doi:10.1001/jamainternmed.2019.0677. This nested case-control study including 58 769 patients ...
Source: JAMA Internal Medicine June 24, 2019 DOI : 10.1001/jamainternmed.2019.0677 Anticholinergic Drug Exposure and the Risk of Dementia ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
JAMA Intern Med. 2019. Epub 2019/06/25. doi: 10.1001/jamainternmed.2019.0677. PubMed PMID: 31233095; PMCID: PMC6593623. I hope this is ...
Coupland et al, JAMA Internal Medecine, doi:10.1001/jamainternmed.2019.0677, 2019 (2) V. Dauphinot et al, Alzheimer's Research & Therapy ...
JAMA Intern Med. Published online June 24, 2019. doi: 10.1001/jamainternmed.2019.0677 (Link). Previous articleThousands of Immigrants ...
JAMA Intern Med. doi:10.1001/jamainternmed.2019.0677. Campbell NL, Holden R, and Boustani MA. Preventing Alzheimer Disease by Deprescribing ...
JAMA Intern Med. (2019) DOI: 10.1001/jamainternmed.2019.0677. Subscribe to Drug Discovery updates for FREE and get: Daily Breaking Science ...
Das individuelle Risiko war nach den Ergebnissen einer Fall-Kontrollstudie in JAMA Internal Medicine (2019; doi: 10.1001/jamainternmed.2019.0677) ...
References: Anticholinergic Drug Exposure and the Risk of Dementia doi:10.1001/jamainternmed.2019.0677.
... JAMA Intern Med. Published online June 24, 2019. doi:10.1001/jamainternmed.2019.0677. Key Points. Question Is the risk of dementia among ...
Carol Coupland et al. JAMA Internal Medicine. doi:10.1001/jamainternmed.2019.0677. Abstract. Anticholinergic Drug Exposure and the Risk of ...
JAMA Intern Med. 2019 Jun 24. doi: 10.1001/jamainternmed.2019.0677. To continue reading this article … Log In. or. Register for Free. Join the ...
Prof Tara Spires-Jones: I have no conflicts with this study. Prof Clive Ballard: No conflicts of interest. doi:10.1001/jamainternmed.2019.0677 ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
... [10.1001/jamainternmed.2019.0677](http: //jamanetwork.com/article. aspx?doi=10.1001%2Fjamainternmed.2019.0677) In this nested case-control ...
Source: Anticholinergic Drug Exposure and the Risk of DementiaA Nested Case-Control Study doi: [10.1001/jamainternmed.2019.0677](http: // ...
A
RM
JM
JM
AM
GS
R
GG
AP
A
に
V
CS
AM
D
MP
社
HC
NP
E
まパ
L
MT
KP
ま
A
DK
EH
IK
L
BH
M
I
P
C
GD
LS
み
T
KW
き勉
B
LV
AH
RR
SM
DB
B
MP
JV
FJ
A
EN
CM
CP
G
Lバ
MG
CR
M
SR
TK
MH
BB
T
AI
M
UG
UU
DH
飴
ち手
KP
SB
B
MO
S
SN
JH
PW
S
HF
FB
S
JD
MR
LF
ET
M
EM
KH
U
E
SC
PS
JH
DD
GH
LA
RV
D
DN
FH
JM
GC
MS
UM
VS
NM
DM
AS
GJ
TT
CL
SM
CC
GD
W
MV
EP
JM
SD
EP
UM
HP
JP
PA
RE
KM